Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis.

Saved in:
Bibliographic Details
Title: Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis.
Authors: Fournier J; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, France. jfournier@chu-grenoble.fr., Boussat B; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, and Laboratory TIMC, UMR 5525, CNRS, Joseph Fourier University, Grenoble, France., Dervaux B; Department of Research and Innovation, CHRU Lille, Lille, France., Gaudin P; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France., Romand X; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France.
Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2025 Jan; Vol. 43 (1), pp. 62-69. Date of Electronic Publication: 2024 Oct 03.
Publication Type: Journal Article
Journal Info: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39360378
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fournier+J%22">Fournier J</searchLink>; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, France. jfournier@chu-grenoble.fr.<br /><searchLink fieldCode="AU" term="%22Boussat+B%22">Boussat B</searchLink>; Department of Epidemiology and Medical Evaluation, CHU Grenoble Alpes, Grenoble, and Laboratory TIMC, UMR 5525, CNRS, Joseph Fourier University, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Dervaux+B%22">Dervaux B</searchLink>; Department of Research and Innovation, CHRU Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Gaudin+P%22">Gaudin P</searchLink>; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Romand+X%22">Romand X</searchLink>; T-RAIG, TIMC, UMR 5525 CNRS, University of Grenoble Alpes, CHU Grenoble Alpes, Grenoble, and Department of Rheumatology, CHU Grenoble Alpes, Grenoble, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228308521%22">Clinical and experimental rheumatology</searchLink> [Clin Exp Rheumatol] 2025 Jan; Vol. 43 (1), pp. 62-69. <i>Date of Electronic Publication: </i>2024 Oct 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Clinical+And+Experimental+Rheumatology+S%2EA%2ES%22">Clinical And Experimental Rheumatology S.A.S </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>8308521 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0392-856X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220392856X%22">0392856X </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39360378
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.55563/clinexprheumatol/3f60yv
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 62
    Titles:
      – TitleFull: Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fournier J
      – PersonEntity:
          Name:
            NameFull: Boussat B
      – PersonEntity:
          Name:
            NameFull: Dervaux B
      – PersonEntity:
          Name:
            NameFull: Gaudin P
      – PersonEntity:
          Name:
            NameFull: Romand X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 0392-856X
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical and experimental rheumatology
              Type: main
ResultId 1